menu
    • menu

    Company profile for RiboX Therapeutics

    NEW Drugs in Dev: 1
    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Sigma-Aldrich empowers scientific discovery with top-quality solutions to accelerate research, innovation, and better health worldwide.

    Virtual Booth

    Contact Supplier

    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Riboxx Therapeutics is dedicated to pioneering RNA-based therapies aimed at treating genetic diseases. We harness the power of RNA technology to develop novel, targeted treatments that address the root causes of complex disorders. By focusing on RNA modulation and innovative drug delivery systems, Riboxx aims to create transformative therapies with the potential to change the lives of patients suffering from genetic and rare d...
    Riboxx Therapeutics is dedicated to pioneering RNA-based therapies aimed at treating genetic diseases. We harness the power of RNA technology to develop novel, targeted treatments that address the root causes of complex disorders. By focusing on RNA modulation and innovative drug delivery systems, Riboxx aims to create transformative therapies with the potential to change the lives of patients suffering from genetic and rare diseases. With a commitment to scientific excellence, we strive to push the boundaries of medicine and unlock new possibilities for better health outcomes.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    RiboX TherapeuticsChina Flag
    Country
    Country
    China
    Address
    Address
    No. 15, Lane 388, Shengrong Road, Pudong New Area, Shanghai
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.riboxtx.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    IMCAS Asia

    IMCAS Asia

    Not Confirmed

    envelop Contact Supplier

    IMCAS Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    RiboX Doses First Patient In Ph1/2a RXRG001 Circular RNA Study
    RiboX Doses First Patient In Ph1/2a RXRG001 Circular RNA Study

    09 Mar 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/ribox-therapeutics-announces-first-patient-dosed-in-phase-iiia-clinical-trial-of-rxrg001-the-first-circular-rna-therapy-for-the-treatment-of-radiation-induced-xerostomia-and-hyposalivation-302395477.html

    PR NEWSWIRE
    09 Mar 2025
    Share Share
    RiboX Announces FDA Clearance for RXRG001 IND Application
    RiboX Announces FDA Clearance for RXRG001 IND Application

    25 Oct 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/ribox-therapeutics-announces-fda-clearance-for-ind-application-of-rxrg001-the-first-circular-rna-therapy-for-the-treatment-of-radiation-induced-xerostomia-and-hyposalivation-302287539.html

    PR NEWSWIRE
    25 Oct 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search